Prophylaxis is the recommended treatment for people with severe haemophilia. It is unlikely that a single prophylactic regimen, for example based on weight, would be optimal for all patients and therefore each individual should have a personalized regimen, agreed between themselves and their haemophilia centre. This regimen should take into account the individual’s bleeding pattern, the condition of their musculoskeletal system, level and timing of physical activity and measurement of coagulation factor in their blood. It is important to recognize that prophylactic regimens are likely to need to change with time as the circumstances of an individual change. For example, activity may change with age or with the season and an individual’s fac...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
Clinical experience over decades and numerous retrospective and, recently, also prospective studies ...
The pharmacokinetic (PK) response to factor VIII (FVIII) and factor IX varies between patients and t...
Prophylaxis is the recommended treatment for people with severe haemophilia. It is unlikely that a s...
Current therapy for haemophilia A is guided by severity of the disease, which in turn is best reflec...
Haemophilia A is a sex-linked disorder characterised chiefly by recurrent, spontaneous joint and mus...
<div><p>Background & aims</p><p>Prophylactic injections of factor VIII reduce the incidence of bleed...
Prophylactic injections of factor VIII reduce the incidence of bleeds and slow the development of jo...
Prophylaxis is defined as the regular administration of clotting factor concentrates to prevent blee...
Prophylaxis entails long-term continuous intravenous administration of concentrates of the deficient...
Owing to the heterogeneity in the clinical phenotype of haemophilia A and B, it is now recognized th...
Haemophilia is a rare hereditary disorder that impairs blood coagulation due to lack of functional c...
Prophylaxis is universally recognized as the treatment of choice in people with hemophilia, and tail...
The hallmark of severe haemophilia, defined as a circulating level of factor (F) VIII (haemophilia A...
Personalization of prophylaxis applying population pharmacokinetic (PK) tools has recently rendered ...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
Clinical experience over decades and numerous retrospective and, recently, also prospective studies ...
The pharmacokinetic (PK) response to factor VIII (FVIII) and factor IX varies between patients and t...
Prophylaxis is the recommended treatment for people with severe haemophilia. It is unlikely that a s...
Current therapy for haemophilia A is guided by severity of the disease, which in turn is best reflec...
Haemophilia A is a sex-linked disorder characterised chiefly by recurrent, spontaneous joint and mus...
<div><p>Background & aims</p><p>Prophylactic injections of factor VIII reduce the incidence of bleed...
Prophylactic injections of factor VIII reduce the incidence of bleeds and slow the development of jo...
Prophylaxis is defined as the regular administration of clotting factor concentrates to prevent blee...
Prophylaxis entails long-term continuous intravenous administration of concentrates of the deficient...
Owing to the heterogeneity in the clinical phenotype of haemophilia A and B, it is now recognized th...
Haemophilia is a rare hereditary disorder that impairs blood coagulation due to lack of functional c...
Prophylaxis is universally recognized as the treatment of choice in people with hemophilia, and tail...
The hallmark of severe haemophilia, defined as a circulating level of factor (F) VIII (haemophilia A...
Personalization of prophylaxis applying population pharmacokinetic (PK) tools has recently rendered ...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
Clinical experience over decades and numerous retrospective and, recently, also prospective studies ...
The pharmacokinetic (PK) response to factor VIII (FVIII) and factor IX varies between patients and t...